All In MedTech

FDA Clearance Tracker · P040021

SJM BIOCOR VALVE / SJM BIOCOR SUPRA VALVE

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 20, 2026Latest source record: Aug 5, 2005 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Aug 5, 2005

Approved

Time to decision

473 days

Received Apr 19, 2004. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P040021
Device name
SJM BIOCOR VALVE / SJM BIOCOR SUPRA VALVE
Applicant location
St. Paul, MN
Received
Apr 19, 2004
Decided
Aug 5, 2005
Decision
Approved
Supplements
60 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code LWR

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE SJM BIOCOR VALVE AND THE SJM BIOCOR SUPRA VALVE.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code LWR. The earliest in FDA's data is P790007, decided Nov 15, 1979.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for ABBOTT MEDICAL

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.